Merck to buy vaccine plant from WuXi Biologics: report
Source: SeekingAlpha
2025-01-06 11:24:08 ET
More on Merck
- Merck: A Low-Hanging Fruit To Pick
- Merck: Healthcare Pharma Giant: 3.2% Yield, 9.3% 5-Year Dividend Growth, Buy Time
- Merck: Buy Opportunity Backed By Growth
- Brand prescription drugs to rise an average 4.5% in 2025
- Merck gets U.K. approval for sotatercept for PAH
Read the full article on Seeking Alpha
For further details see:
Merck to buy vaccine plant from WuXi Biologics: report
Wuxi Biologics Cayman Inc
NASDAQ: WXIBF
WXIBF Trading
0.0% G/L:
$4.60 Last:
5,000 Volume:
$4.60 Open:
